Aperture Sectors › Healthcare & Life Sciences › Life-science research tools
Life-science research tools funding
Life-science research tools
A sub-sector of Healthcare & Life Sciences. Each company counts once, in its main sub-sector.
32 rounds, $430M raised by 29 companies, Jan 2, 2023 to Nov 14, 2026, 1% of Healthcare & Life Sciences capital. Top three companies: Somite AI 12%, bit.bio 12%, Portal Biotech 8%.
| Company | HQ | Capital raised | Rounds | Exit |
|---|---|---|---|---|
| Somite AI | United States | $52M | 2 | — |
| bit.bio | United Kingdom | $50M | 1 | — |
| Portal Biotech | United Kingdom | $35M | 1 | — |
| Tahoe Therapeutics | United States | $30M | 1 | — |
| Ramona Optics | United States | $25M | 1 | — |
| Transfyr | United States | $25M | 1 | — |
| Polyphron | United States | $20M | 1 | — |
| Mithrl | United States | $20M | 1 | — |
| Pumpkinseed Technologies | United States | $20M | 1 | — |
| Reshape Biotechnology | Denmark | $20M | 1 | — |
| Dash Bio | United States | $18M | 2 | — |
| Syncell | Taiwan | $15M | 1 | — |
| BOYI Group (伯仪集团) | China | $15M | 1 | — |
| Omix Science | China | $15M | 1 | — |
| Phylo | United States | $14M | 1 | — |
| Stately Bio | United States | $12M | 1 | — |
| LattixOrigin (格原万维) | China | $10M | 1 | — |
| MiLaboratories | United States | $10M | 1 | — |
| CellVoyant | United Kingdom | $9.6M | 1 | — |
| 10x Science | United States | $4.8M | 1 | — |
| Sequential | United Kingdom | $3.5M | 1 | — |
| Cytely | Sweden | $3.5M | 1 | — |
| Stratum Biosciences | United States | $2M | 1 | — |
| Yuanbo Biotech | China | $1.3M | 1 | — |
| Jindu Biotechnology | China | $0 | 2 | — |
| Company | Amount | Stage | Announced |
|---|---|---|---|
| bit.bio | $50M | Series C | Jan 9, 2026 |
| Somite AI | $47M | Series A | May 14, 2025 |
| Portal Biotech | $35M | Series A | Jun 30, 2025 |
| Tahoe Therapeutics | $30M | Series A | Aug 11, 2025 |
| Ramona Optics | $25M | Series A | Sep 22, 2026 |
| Transfyr | $25M | Seed | Aug 26, 2026 |
| Polyphron | $20M | Seed | Sep 17, 2026 |
| Mithrl | $20M | Series A | Sep 15, 2026 |
| Pumpkinseed Technologies | $20M | Series A | May 1, 2026 |
| Reshape Biotechnology | $20M | Series A | Apr 9, 2024 |